These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

758 related items for PubMed ID: 18959493

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D, McCracken GH.
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [Abstract] [Full Text] [Related]

  • 3. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ, Klugman KP, Pichichero M.
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [Abstract] [Full Text] [Related]

  • 4. Serotype 19A is the most common Streptococcus pneumoniae isolate in children with chronic sinusitis.
    McNeil JC, Hulten KG, Mason EO, Kaplan SL.
    Pediatr Infect Dis J; 2009 Sep; 28(9):766-8. PubMed ID: 19636285
    [Abstract] [Full Text] [Related]

  • 5. Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine.
    Aguiar SI, Serrano I, Pinto FR, Melo-Cristino J, Ramirez M, Portuguese Surveillance Group for the Study of Respiratory Pathogens.
    Clin Microbiol Infect; 2008 Sep; 14(9):835-43. PubMed ID: 18844684
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
    Hsu KK, Shea KM, Stevenson AE, Pelton SI, Massachusetts Department of Public Health.
    Pediatr Infect Dis J; 2010 Apr; 29(4):289-93. PubMed ID: 19935447
    [Abstract] [Full Text] [Related]

  • 10. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.
    Muñoz-Almagro C, Jordan I, Gene A, Latorre C, Garcia-Garcia JJ, Pallares R.
    Clin Infect Dis; 2008 Jan 15; 46(2):174-82. PubMed ID: 18171247
    [Abstract] [Full Text] [Related]

  • 11. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ.
    Clin Microbiol Infect; 2009 Apr 15; 15 Suppl 3():4-6. PubMed ID: 19366362
    [Abstract] [Full Text] [Related]

  • 12. Herd immunity and pneumococcal conjugate vaccine: a quantitative model.
    Haber M, Barskey A, Baughman W, Barker L, Whitney CG, Shaw KM, Orenstein W, Stephens DS.
    Vaccine; 2007 Jul 20; 25(29):5390-8. PubMed ID: 17583392
    [Abstract] [Full Text] [Related]

  • 13. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.
    Moore MR, Gertz RE, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Gershman K, Reingold A, Farley M, Harrison LH, Hadler JL, Bennett NM, Thomas AR, McGee L, Pilishvili T, Brueggemann AB, Whitney CG, Jorgensen JH, Beall B.
    J Infect Dis; 2008 Apr 01; 197(7):1016-27. PubMed ID: 18419539
    [Abstract] [Full Text] [Related]

  • 14. Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine.
    Dias R, Caniça M.
    FEMS Immunol Med Microbiol; 2007 Oct 01; 51(1):35-42. PubMed ID: 17854472
    [Abstract] [Full Text] [Related]

  • 15. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E, Albert MJ.
    Vaccine; 2012 Dec 31; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [Abstract] [Full Text] [Related]

  • 16. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.
    Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ, Scheifele DW.
    Clin Infect Dis; 2009 Jul 15; 49(2):205-12. PubMed ID: 19508165
    [Abstract] [Full Text] [Related]

  • 17. Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media.
    Joloba ML, Windau A, Bajaksouzian S, Appelbaum PC, Hausdorff WP, Jacobs MR.
    Clin Infect Dis; 2001 Nov 01; 33(9):1489-94. PubMed ID: 11588694
    [Abstract] [Full Text] [Related]

  • 18. Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine.
    Gonzalez BE, Hulten KG, Lamberth L, Kaplan SL, Mason EO, U.S. Pediatric Multicenter Pneumococcal Surveillance Group.
    Pediatr Infect Dis J; 2006 Apr 01; 25(4):301-5. PubMed ID: 16567980
    [Abstract] [Full Text] [Related]

  • 19. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?
    Fenoll A, Aguilar L, Granizo JJ, Giménez MJ, Aragoneses-Fenoll L, Mendez C, Tarragó D.
    J Antimicrob Chemother; 2008 Dec 01; 62(6):1430-3. PubMed ID: 18819966
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.